Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
SLNO
SLNO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest SLNO ETF News Today | Earnings, Events & Price Alerts
SLNO News
Aardvark Pauses PWS Trial, Shares Plunge 53%
4d ago
stocktwits
Soleno Therapeutics Appoints New CFO
5d ago
seekingalpha
Soleno Therapeutics Q4 2025 Earnings Highlights
6d ago
seekingalpha
Soleno Therapeutics Q4 Earnings Beat Expectations
6d ago
seekingalpha
Soleno Therapeutics to Announce Q4 Earnings on February 25
Feb 24 2026
seekingalpha
RBC Initiates Coverage on Rhythm Pharmaceuticals with Outperform Rating
Feb 19 2026
Benzinga
Brookfield to Acquire Peakstone Realty Trust for $1.2 Billion
Feb 02 2026
Benzinga
Soleno Therapeutics Under Investigation for Securities Violations Amid 40% Stock Decline
Jan 20 2026
Globenewswire
Soleno Therapeutics Under Investigation, Shares Plunge 26.59%
Jan 17 2026
Globenewswire
Soleno Therapeutics (SLNO) Shares Plunge 28% Following VYKAT™ XR Disappointment
Jan 16 2026
Globenewswire
Soleno Therapeutics Shares Drop 26.59% Following Safety Concerns Over Vykat XR
Jan 12 2026
Businesswire
Soleno Therapeutics Faces Investigation After Vykat XR Price Drop of 26.59%
Jan 09 2026
Globenewswire
Bragar Eagel & Squire Investigates Soleno, Avita, and Coty for Potential Securities Violations
Jan 08 2026
Globenewswire
Soleno Therapeutics Faces Investigation Over Vykat XR Safety Claims, Stock Plummets 26.59%
Jan 06 2026
Globenewswire
Soleno Therapeutics Faces Investigation Over Vykat XR, Stock Plummets 26.59%
Jan 01 2026
PRnewswire
Soleno Therapeutics Faces Investigation After Vykat XR Price Drop of 26.59%
Dec 31 2025
Businesswire
Show More News
